Boult Wade Tennant
Service » Global plant breeders’ rights and national listings

We have a growing practice and specialist expertise in supporting major horticultural and biopharma clients in relation to plant breeders’ rights and national listings. The team is equipped to assist clients in national listings for plant varieties within the UK as well as obtaining rights across Europe. We also offer expert advice on the potential infringement risks associated with plant variety rights held by third parties.

 

What we do

Secure and preserve
  • We have significant experience in filing and prosecuting applications for plant breeders’ rights (known as plant variety rights in some countries) and national listings in the UK for our clients.
  • In this regard, we regularly act before the Plant Variety Rights Office of the UK Animal and Plant Health Agency (APHA) and have filed many applications using UPOV PRISMA.
  • We are regularly appointed as agent for existing UK plant breeders’ rights, particularly those created when the UK left the EU, and based upon former corresponding Community plant variety rights.
  • We are also able to coordinate the filing of plant variety right and national listing applications outside of the UK, including in the EU.

Technical toolkits

Services

image
Patents

Our European, UK and German experts advise on the creation, exploitation and enforcement of IP rights across a wide range of sectors. They provide creative IP solutions and outstanding client service.

MORE
image
Trade Marks

Our highly skilled experts are experienced negotiators and have particular expertise in the management of large portfolios; searching and watching; domain name recovery; and trading standards and customs work.

MORE
image
Design Rights

The team can advise clients across a wide range of industries on matters of design law and practice. They combine their commercial knowledge with legal expertise to provide high quality advice that is always pragmatic.

MORE

Insights

image
IP updates
Omnia v Sidel appeal confirms: if you intend to opt out, do it early

In Omnia v Sidel, the UPC Court of Appeal confirmed proceedings can be brought before a European patent is granted, reinforcing the need to file UPC opt-outs soon after publication.

image
IP updates
From formulations to ingredients: how consumer behaviour is changing skincare patent strategy

As consumers increasingly choose skincare based on ingredients like retinol and niacinamide, companies may need to rethink patent strategies, placing greater emphasis on manufacturing innovation.

image
IP updates
The UK-Swiss trade deal: boosting innovation in pharma and biotech

The enhanced UK-Switzerland FTA provides greater certainty on IP rights and exclusivity, supports cross-border collaboration and investment and streamlines talent mobility for pharma and biotech innovators.

image
IP updates
The freedom to operate questions every deep-tech company should ask

A patent does not automatically grant the right to commercialise. Discover how competitor patent watching helps deep-tech businesses identify risks, monitor rivals and prepare for future freedom-to-operate reviews.

INSIGHTS

Patents